This is a 2-3 period parallel group study with an adaptive element in Type 2 diabetes patients receiving vildagliptin as add-on therapy to metformin
Inclusion Criteria:
Exclusion Criteria:
Buenos Aires, Santa Fe Province 3000FNF, Argentina
Bibertal, 89346, Germany
Falkensee, 14612, Germany
Hyderabaad, 500 036, India
Hyderabaad, 500 082, India
Mexico City, Durango 03300, Mexico
Valencia, Carabobo, Venezuela
Caracas, Piso 4. Urb., Venezuela